Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00867633

Enrollment

100

Registered

2009-03-24

Start date

2009-03-31

Completion date

2012-03-31

Last updated

2012-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial Carcinoma

Keywords

urothelial carinoma, aristolochic acid, DNA, adduct

Brief summary

To study the association between aristolochic acid and urothelial carcinoma in Taiwan

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* the resected kidney tissue in the tissue bank

Exclusion criteria

* the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.

Design outcomes

Primary

Measure	Time frame
the incidence of aristolochic-acid DNA adduct in the samples	one week

Countries

Taiwan

Contacts

Primary ContactYeong-Shiau Pu, Ph.D.

yspu@ntu.edu.tw886-2-23123456

Outcome results